L PERRIGO CO FDA Approval ANDA 075217

ANDA 075217

L PERRIGO CO

FDA Drug Application

Application #075217

Documents

Letter1998-12-16
Label1998-12-16
Review1998-12-16

Application Sponsors

ANDA 075217L PERRIGO CO

Marketing Status

Over-the-counter001

Application Products

001SUSPENSION/DROPS;ORAL40MG/ML0IBUPROFENIBUPROFEN

FDA Submissions

ORIG1AP1998-12-16
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2000-05-24
LABELING; LabelingSUPPL3AP2000-05-24
LABELING; LabelingSUPPL4AP2000-10-18
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2001-06-14
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2001-08-21
LABELING; LabelingSUPPL9AP2003-05-22
LABELING; LabelingSUPPL26AP2006-03-22
LABELING; LabelingSUPPL38AP2011-05-24

Submissions Property Types

SUPPL2Null0
SUPPL5Null0
SUPPL6Null0

CDER Filings

L PERRIGO CO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75217
            [companyName] => L PERRIGO CO
            [docInserts] => ["",""]
            [products] => [{"drugName":"IBUPROFEN","activeIngredients":"IBUPROFEN","strength":"40MG\/ML","dosageForm":"SUSPENSION\/DROPS;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"12\/16\/1998","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/anda\\\/98\\\/75-217_Ibuprofen_prntlbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"IBUPROFEN","submission":"IBUPROFEN","actionType":"40MG\/ML","submissionClassification":"SUSPENSION\/DROPS;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1998-12-16
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.